CS

Cevdet Samikoglu

Chief Executive Officer

Biosplice Therapeutics

San Diego, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Biosplice Therapeutics
Industry
biotechnology
Employees
37.0
Seniority
C suite
Annual Revenue
4000000.0
Total Funding
558000000.0
Latest Funding
Other

Technologies

Outlook Microsoft Office 365 Microsoft Azure Hosting Mobile Friendly Google Tag Manager StatCounter Google Analytics AI Remote

Keywords

alternative splicing therapies osteoarthritis oncology neurology diabetes biological insights chemical equity therapeutic modulation clk/dyrk family kinases drug targets rna splice-sites proteome diversification clinical development clinical trials drug therapy tissue specialization cellular reprogramming small molecules therapeutic potential unmet medical need biotherapeutics innovative treatments scientific platform proteins disease-selective network signaling wnt signaling dysregulated splicing developmental disorders tissue degeneration patient care investigational treatments compassionate use safety & efficacy treatment options research studies preclinical studies health restoration therapeutic innovation biomedical research clinical research patients molecular pathways disease mechanisms cross-disciplinary research healthcare solutions hospital & health care medical health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans